576 related articles for article (PubMed ID: 23440788)
1. Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.
Albuquerque LE; Tso LO; Saconato H; Albuquerque MC; Macedo CR
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD002808. PubMed ID: 23440788
[TBL] [Abstract][Full Text] [Related]
2. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2005 Jan; (1):CD002808. PubMed ID: 15674898
[TBL] [Abstract][Full Text] [Related]
3. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Siristatidis CS; Gibreel A; Basios G; Maheshwari A; Bhattacharya S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD006919. PubMed ID: 26558801
[TBL] [Abstract][Full Text] [Related]
4. Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles.
Albuquerque LE; Saconato H; Maciel MC
Cochrane Database Syst Rev; 2002; (3):CD002808. PubMed ID: 12137658
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction.
Maheshwari A; Gibreel A; Siristatidis CS; Bhattacharya S
Cochrane Database Syst Rev; 2011 Aug; (8):CD006919. PubMed ID: 21833958
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology.
Youssef MA; Van der Veen F; Al-Inany HG; Mochtar MH; Griesinger G; Nagi Mohesen M; Aboulfoutouh I; van Wely M
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008046. PubMed ID: 25358904
[TBL] [Abstract][Full Text] [Related]
7. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
Tso LO; Costello MF; Albuquerque LET; Andriolo RB; Macedo CR
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006105. PubMed ID: 33347618
[TBL] [Abstract][Full Text] [Related]
8. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.
Al-Inany HG; Youssef MA; Ayeleke RO; Brown J; Lam WS; Broekmans FJ
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD001750. PubMed ID: 27126581
[TBL] [Abstract][Full Text] [Related]
9. Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.
Kamath MS; Maheshwari A; Bhattacharya S; Lor KY; Gibreel A
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008528. PubMed ID: 29096046
[TBL] [Abstract][Full Text] [Related]
10. Natural cycle in vitro fertilisation (IVF) for subfertile couples.
Allersma T; Farquhar C; Cantineau AE
Cochrane Database Syst Rev; 2013 Aug; 2013(8):CD010550. PubMed ID: 23990351
[TBL] [Abstract][Full Text] [Related]
11. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
[TBL] [Abstract][Full Text] [Related]
12. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
[TBL] [Abstract][Full Text] [Related]
14. Long-acting FSH versus daily FSH for women undergoing assisted reproduction.
Pouwer AW; Farquhar C; Kremer JA
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009577. PubMed ID: 26171903
[TBL] [Abstract][Full Text] [Related]
15. Cycle regimens for frozen-thawed embryo transfer.
Ghobara T; Gelbaya TA; Ayeleke RO
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD003414. PubMed ID: 28675921
[TBL] [Abstract][Full Text] [Related]
16. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF/ICSI cycles.
Mochtar MH; Danhof NA; Ayeleke RO; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2017 May; 5(5):CD005070. PubMed ID: 28537052
[TBL] [Abstract][Full Text] [Related]
17. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
Ngwenya O; Lensen SF; Vail A; Mol BWJ; Broekmans FJ; Wilkinson J
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD012693. PubMed ID: 38174816
[TBL] [Abstract][Full Text] [Related]
18. Recombinant versus urinary human chorionic gonadotrophin for final oocyte maturation triggering in IVF and ICSI cycles.
Youssef MA; Abou-Setta AM; Lam WS
Cochrane Database Syst Rev; 2016 Apr; 4(4):CD003719. PubMed ID: 27106604
[TBL] [Abstract][Full Text] [Related]
19. WITHDRAWN: Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles.
Westergaard LW; Bossuyt PM; Van der Veen F; van Wely M
Cochrane Database Syst Rev; 2011 Feb; 2011(2):CD003973. PubMed ID: 21328264
[TBL] [Abstract][Full Text] [Related]
20. Luteal phase support for assisted reproduction cycles.
van der Linden M; Buckingham K; Farquhar C; Kremer JA; Metwally M
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD009154. PubMed ID: 26148507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]